Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Compumedics Limited ( (AU:CMP) ) has issued an announcement.
Compumedics Limited has signed two new 4-year distribution agreements in China, valued at A$24.4 million, with long-term partners. These agreements, which include a minimum 10% annual growth commitment, aim to strengthen Compumedics’ presence in Northern and Eastern China, focusing on sleep diagnostics and neurology. This strategic move is part of Compumedics’ broader effort to diversify and stabilize its revenue streams geographically and across product lines, positioning the company for sustained growth in key international markets, particularly in Asia.
More about Compumedics Limited
Compumedics Limited is a global medical device company that develops, manufactures, and commercializes diagnostic technology for sleep, brain, and ultrasonic blood flow monitoring applications. The company has a broad international reach, including the Americas, Australia and Asia Pacific, Europe, and the Middle East. Founded in 1987, Compumedics has been recognized for its innovation and has received numerous awards, including Australia’s Exporter of the Year.
Average Trading Volume: 45,000
Technical Sentiment Signal: Buy
Current Market Cap: A$56.7M
See more data about CMP stock on TipRanks’ Stock Analysis page.